Autonomix Medical
AMIX | NASDAQ
$1.27
-$0.10 (-7.30%)
At close: Nov 16, 2026, 3:59 PM ET
$1.07
-$0.20 (-15.75%)
After-hours:
Nov 16, 2026, 7:54 PM ET
-7.30%
(1D)No price chart data available for 1D timeframe.
Rating
32.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #740/1021 (Top 72%)
Key Statistics
Market Data
Market Cap $1.58M
1D Range
1.25 1.41
52W Range
1.25 24.15
Valuation (TTM)
PE -0.06
PB 0.23
EV/EBITDA 0.52
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $2.00
Cash Flow
FCF Yield -759.7%
SBC Adj. FCF Yield -763.4%
SBC Impact -0.5%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y 97.4% |
N/A
FCF 3Y | 5Y -16.8% |
N/A
Returns
ROA -143.8%
ROE -191.9%
ROIC -173.3%
Financial Health
Net Cash
$7.69M
Current Ratio 6.52
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s techn...
Sector Healthcare
Industry Medical - Devices
Employees 10
IPO Date Jan 29, 2024
Website autonomix.com
Fiscal Year April - March
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$2.00
Upside
+57.48%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove AMIX